5 ms·
Assuming you're not one unlucky enough to need it, sure, it makes perfect sense. <blunt> But if you're unlucky enough to have a baby that gets toxoplasmosis,
by falcolas 9y ago
Assuming you're not one unlucky enough to need it, sure, it makes perfect sense.
<blunt>
But if you're unlucky enough to have a baby that gets toxoplasmosis, you're fucked. The people backing the insurance which is paying that new price are fucked. But it's OK that this is a net negative for society, because the company is now making a 'proper' amount profit off it, right?
</blunt>
- loceng 9y agoThe only argument I can see a company going towards is opportunity cost, where they could be using facilities to create more profit, however that simply continues to highlight a problem with how we allow things to be structured, a failure of or complete lack of necessary safeguards.
- Consultant32452 9y agoWhen you write "more profit" I read "helps even more people."
- monocasa 9y agoThat's a big leap. The entire point of buying orphan drug companies like this is the rent seeking.
- Consultant32452 9y agoThe orphan drug company sold for a reason. It's a false assumption to assume the product would've continued to be available at the same price indefinitely.
- loceng 9y agoWhich is what I am talking about regarding a lack of a fail-safe, whereby public intervention could takeover and maintain production - so either companies can be honest with their costs and take a reasonable profit, or things move to the fail-safe; what would trigger that mechanism would have to be figured out/decided.
- Consultant32452 9y agoFor out of patent drugs, nothing is stopping you from funding such a fail-safe. The problem is you'll run into the question of is this the most social benefit for your dollar spend. I suspect not, but that's for you to decide.
- loceng 9y agoPerhaps sold because the parent company wouldn't want to be associated with immoral activity like price gouging, however could sell at a higher amount to someone willing to start gouging; who initiates these transactions would also be interesting to look at.
- Consultant32452 9y agoNone of that matters for out of patent drugs. If there's a massive profit to be made here, make it.
- morogop 9y agome, an idiot: "This company that is not investing in R&D is probably not creating drugs." you, a genius: "This company that is not investing in R&D is magically creating miracle drugs through the power of Ayn Rand"
- chrisbennet 9y agoA similar company, Valeant bought drug companies, raised prices and slashed R&D. Bid for Allergan Puts Valeant's Research and Development Cuts Under Scrutiny $53 Billion Bid Puts Focus on Strategy of Shedding Research Operations and Making Money Selling Products https://www.wsj.com/articles/bid-for-allergan-puts-valeants-research-and-development-cuts-under-scrutiny-1402443053 https://www.wsj.com/articles/bid-for-allergan-puts-valeants-...
- Consultant32452 9y agoYou don't have enough information to determine if it's a net negative to society. You don't even have enough information to determine it's a net negative for the unfortunate baby with toxoplasmosis, since at $13 there might not be any supply. Since it's out of patent, you're free to start manufacturing and selling it at $13 if you want.
- kristopolous 9y ago> you're free to start manufacturing and selling it...if you want. This common apologetic ignores the real-world cost of infrastructure, overhead, and accruing a user-base that an existing company has already established. It excuses irresponsibility and negligence of the public trust. Nobody would say, for instance, "corrupt politician? You're free to stage a revolution, overthrow the existing state, draft a constitution, establish a sovereign power and diplomatic ties with other states if you want" No, we know how absurd and ridiculous that is, so we have tried to create reasonable mechanisms for dealing with political corruption through the ballot box and removing barriers to entry for legitimate challengers. But in business, this trope is implying "You're free to abandon your career, study chemical engineering, get financing to start a lab, hire a large staff of experts, buy the machinery, run an advertising campaign, establish the customer base ..." It changes the frame of reference from abuse and incompetence on important matters to essentially shaming people for not starting multiple successful industrial capitalist enterprises in their leisure time. There needs to be more reasonable mechanisms for dealing with abuses of power then requiring such expensive and elaborate responses. Otherwise most abuses go unchallenged.
- paulriddle 9y ago> But in business, this trope is implying "You're free to abandon your career, study chemical engineering, get financing to start a lab, hire a large staff of experts, buy the machinery, run an advertising campaign, establish the customer base ..." On the other hand, this trope also implies that you have to pay for all of this, and perphaps $13 is not a good price for the drug. What is an appropriate price for this drug? You say it's abuse and incompetence, but could it be that you're wrong and it's a rational decision?
- toomuchtodo 9y agoTuring Pharma (Shkreli's company) only raised the price for insurance companies. If you could not afford it, you were provided it for free or at a steep discount. The outrage at Shkreli is misdirected. Be outraged at the system, not someone acting rationally within the system. If you're upset drugs are too expensive, argue and work towards non-profit manufacturing. If drugs aren't profitable, they cannot be manufactured. Equipment, technicians, supply chains, and FDA regulatory compliance all cost money.
- monocasa 9y agoThere's enough outrage to go around.
- toomuchtodo 9y agoI don't see anyone still outraged at insurance companies and Big Pharma, or doing anything about it. Shkreli was made an example of, and everyone went on with their day, grumbling that the system is still broken.
- crescentfresh 9y ago> only raised the price for insurance companies. If you could not afford it, you were provided it for free Wow I had no idea. Source? If true I certainly am guilty of misdirected outrage.
- toomuchtodo 9y agohttps://www.vanityfair.com/news/2015/12/martin-shkreli-pharmaceuticals-ceo-interview https://www.vanityfair.com/news/2015/12/martin-shkreli-pharm... "In one breath, he calls himself a capitalist and in the next an altruist—the latter because, he claims, his real goal is to invent new drugs for rare diseases. Turing recently announced discounts of Daraprim for hospitals, and Shkreli says that for people without insurance it will cost only $1 a pill. For everyone else, insurance, which he argues is paid for by corporate America’s profits, will cover the cost. “I’m like Robin Hood,” he continues. “I’m taking Walmart’s money and doing research for diseases no one cares about.”" http://money.cnn.com/2015/11/25/news/companies/turing-pharmaceuticals-daraprim-price-drop/index.html http://money.cnn.com/2015/11/25/news/companies/turing-pharma... "Turing said it would offer smaller bottles of 30 tablets to make it easier and cheaper for hospitals to carry the drug, and free sample packages for doctors needing to treat patients in emergency situations. The company estimates that "nearly all patients will receive Daraprim for $10 or less out-of-pocket per prescription. While Turing is dropping the price for hospitals, it is not reducing the list price of Daraprim at pharmacies, because that would not help patients, Retzlaff said." https://www.thepharmaletter.com/article/turing-pharma-reduces-cost-of-daraprim-in-the-usa https://www.thepharmaletter.com/article/turing-pharma-reduce... "Additionally for the outpatient setting, Turing will continue to: * Participate in federal and state programs such as Medicaid and the Section 340B discount program having costs as low as $1 per 100-pill bottle, which currently account for about two-thirds of Daraprim sales. (!!!) * Commit to patients with commercial insurance that their out-of-pocket obligation will be no more than $10 per prescription when Turing's co-pay program is used. * Contribute to Patient Services Inc (PSI), a longstanding independent charity that provides financial assistance for Medicare patients' cost-sharing requirements on toxoplasmosis therapies, consistent with PSI's advisory opinion from the HHS Office of Inspector General. * Provide Daraprim free-of-charge to uninsured, qualified patients with demonstrated income at or below 500% of the federal poverty level through our Patient Assistance Program."
- ythn 9y agoHealthcare is such an emotionally driven topic. It's the only industry where people have the audacity to say that companies should make a drug for cheap, losing money in the process, because it save a small handful of people per year. Yet this logic can be applied to anything. Should food companies make healthy food cheaper at a loss so that more people get the nutrients they need and thus live longer?
- falcolas 9y agoPer TFA, it wasn't being sold at a loss, it just wasn't being sold at great profit.